Table 3.
Sensitivity rates of gram negative microorganisms obtained in urine cultures against various antibiotics
| Escherichia coli 268 | Klebsiella spp. 47 | Enterobacter spp 42 | Proteus spp. 20 | |||||
|---|---|---|---|---|---|---|---|---|
| Amikacin | 242/250 | 96.8% | 45/45 | 100% | 12/12 | 100% | 18/18 | 100% |
| Amoxycilline-clavulanate | 165/253 | 65.2% | 29/44 | 65.9% | 6/13 | 46.1% | 14/17 | 82.3% |
| Ampicillin | 172/247 | 69.6% | 3/44 | 6.8% | 2/12 | 16.6% | 8/15 | 53.3% |
| Phosphamycine | 194/242 | 80.1% | 18/43 | 41.8% | 13/21 | 61.9% | 12/18 | 66.6% |
| Gentamycin | 220/253 | 86.9% | 43/45 | 95.5% | 33/35 | 94.2% | 18/19 | 94.7% |
| Imipenem | 251/251 | 100% | 41/42 | 97.6% | 13/13 | 100% | 19/20 | 95.0% |
| Meropenem | 254/254 | 100% | 45/46 | 97.8% | 13/13 | 100% | 20/20 | 100% |
| Nitrofurantoin | 244/253 | 96.4% | 40/45 | 88.8% | 34/36 | 94.4% | 3/20 | 15.0% |
| Norfloxacin | 227/251 | 90.4% | 42/43 | 97.6% | 24/32 | 75.0% | 19/19 | 100% |
| Piperacillin | 118/227 | 51.9% | 25/40 | 62.5% | 10/13 | 76.9% | 13/17 | 76.4% |
| Cefalotin | 90/237 | 37.9% | 27/42 | 64.2% | 5/16 | 31.2% | 11/15 | 73.3% |
| Cefoperazone | 177/229 | 77.2% | 33/41 | 80.4% | 9/13 | 69.2% | 15/16 | 93.7% |
| Cefazoline | 169/243 | 69.5% | 32/41 | 78.0% | 4/7 | 57.1% | 13/18 | 72.2% |
| Cefepime | 221/230 | 96.0% | 38/39 | 97.4% | 12/12 | 100% | 17/17 | 100% |
| Cefixime | 180/244 | 73.7% | 35/41 | 85.3% | 6/23 | 26.0% | 17/18 | 94.4% |
| Ceftazidime | 228/256 | 89.0% | 43/45 | 95.5% | 12/13 | 92.3% | 19/20 | 95.0% |
| Ceftriaxone | 215/259 | 83.0% | 43/46 | 93.4% | 10/13 | 76.9% | 19/20 | 95.0% |
| Cefuroxim | 188/236 | 79.6% | 32/44 | 72.7% | 4/10 | 40.0% | 16/18 | 88.8% |
| Ciprofloxacin | 232/256 | 90.6% | 45/46 | 97.8% | 31/37 | 83.7% | 20/20 | 100% |
| TMP-SMX | 147/258 | 56.9% | 37/45 | 82.2% | 12/15 | 80.0% | 11/17 | 64.7% |
*
calculated by number of sensitive microorganisms/number of samples studied.
TMP-SMX: trimethoptim-sulfamethoxazole